Viewing Study NCT06544460


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2026-02-21 @ 4:09 AM
Study NCT ID: NCT06544460
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-08-09
First Post: 2024-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ovarian cancer View
None hyperthermic intraperitoneal chemotherapy View
None secondary cytoreduction View